Sector : Pharmaceuticals and health care | Smallcap | BSE
Date Time | Announcment |
|---|---|
| Apr 07, 2026, 8:32 PM IST | Samrat Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 07, 2026, 8:11 PM IST | Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 30, 2026, 8:10 PM IST | Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Mar 25, 2026, 8:21 PM IST | Samrat Pharma - Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31, 2026 |
| Feb 13, 2026, 11:40 PM IST | Samrat Pharma - Board Meeting Outcome for Outcome Of The Board Meeting Held Today |
| Feb 13, 2026, 11:36 PM IST | Samrat Pharma - Un-Audited Financial Results For The Quarter Ended December 31, 2025 |
| Jan 12, 2026, 8:17 PM IST | Samrat Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 29, 2025, 8:43 PM IST | Samrat Pharma - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31, 2025 |
| Dec 02, 2025, 8:58 PM IST | Samrat Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Nov 15, 2025, 2:15 AM IST | Samrat Pharma - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025 |
1 of 8 pages
✕
Market Pulse